Danica Z.
- Country
- Czechia
- Department
- Pediatric Oncology Department
Research Overview
Data & Insights
Has run more than one trial at 26 of 127 partner sites.
Specializations
Pediatric Oncology
This investigator specializes in treating childhood acute lymphoblastic leukemia, with particular emphasis on high-risk cases and relapsed conditions. Their research focuses on innovative therapeutic approaches for young patients between ages 1 and 18.
- Pediatric blood cancers
- High-risk leukemia management
- Relapsed ALL treatment
Their expertise extends to managing complex cases of B-cell precursor acute lymphoblastic leukemia in pediatric populations.
Immunotherapy Research
The investigator explores targeted immunotherapeutic approaches, particularly focusing on CD22-positive leukemia treatments. Their work involves evaluating novel therapeutic agents for improved patient outcomes.
- Targeted therapy development
- Monotherapy applications
- Immunological interventions
Their research encompasses innovative approaches to bone marrow relapse treatment in pediatric patients.
Clinical Innovation
The investigator is dedicated to advancing treatment protocols for high-risk leukemia cases, focusing on comparative therapeutic approaches and treatment optimization.
- Treatment protocol development
- Therapeutic comparative studies
- Clinical outcome assessment
Their work aims to establish superior treatment options for challenging pediatric leukemia cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.